Ethan Rubinstein
Section of Infectious Diseases
University of Manitoba
Winnipeg
Manitoba
Canada
Name/email consistency: high
- Endogenous Endophthalmitis Caused by Hypermucoviscous Klebsiella pneumoniae: An Emerging Disease in Southeast Asia and Beyond. Keynan, Y., Rubinstein, E. Curr. Infect. Dis. Rep (2008)
- Staphylococcus aureus bacteraemia with known sources. Rubinstein, E. Int. J. Antimicrob. Agents (2008)
- Short antibiotic treatment courses or how short is short?. Rubinstein, E. Int. J. Antimicrob. Agents (2007)
- Tigecycline: a novel glycylcycline. Rubinstein, E., Vaughan, D. Drugs (2005)
- Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies. Rubinstein, E., Isturiz, R., Standiford, H.C., Smith, L.G., Oliphant, T.H., Cammarata, S., Hafkin, B., Le, V., Remington, J. Antimicrob. Agents Chemother. (2003)
- Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Rubinstein, E., Cammarata, S., Oliphant, T., Wunderink, R. Clin. Infect. Dis. (2001)
- Comparative safety of the different macrolides. Rubinstein, E. Int. J. Antimicrob. Agents (2001)